Business Segment Information (Tables)

3 Months Ended

Mar. 29, 2025

Segment Reporting [Abstract]

Schedule of Business Segment Information

2025

	Three months ended March 29, 2025
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	1,954	$	1,677	$	1,130	$	5,603	$	10,364
Intersegment revenues	387		41		18		37		482
	2,341		1,718		1,148		5,640		10,846
Elimination of intersegment revenues									(482)
Consolidated revenues									$	10,364
Segment Income
Cost of revenues	856		836		679		4,424
Selling, general, and administrative expenses	470		314		171		592
Research and development expenses	137		137		45		13
Other segment items	44		31		(51)		(120)
Segment income	834		399		304		731		2,269
Unallocated amounts
Cost of revenues adjustments									(11)
Selling, general and administrative expenses adjustments									(14)
Restructuring and other costs									(98)
Amortization of acquisition-related intangible assets									(429)
Interest income									203
Interest expense									(303)
Other income/(expense)									3
Consolidated income before income taxes									$	1,620

(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	85,272	$	3,018	$	2,986	$	1,298	$	6,467	$	99,041
Purchases of property, plant and equipment	36		43		44		33		205		362
Depreciation of property, plant and equipment	—		59		24		22		172		276

2024

	Three months ended March 30, 2024
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	1,930	$	1,629	$	1,099	$	5,686	$	10,345
Intersegment revenues	355		58		10		37		460
	2,285		1,687		1,109		5,723		10,805
Elimination of intersegment revenues									(460)
Consolidated revenues									$	10,345
Segment Income
Cost of revenues	821		799		628		4,500
Selling, general, and administrative expenses	431		318		187		585
Research and development expenses	132		132		40		17
Other segment items	61		39		(40)		(123)
Segment income	840		400		294		744		2,278
Unallocated amounts
Cost of revenues adjustments									(15)
Selling, general and administrative expenses adjustments									(19)
Restructuring and other costs									(29)
Amortization of acquisition-related intangible assets									(551)
Interest income									279
Interest expense									(363)
Other income/(expense)									10
Consolidated income before income taxes									$	1,589

(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	83,908	$	3,114	$	2,671	$	1,179	$	6,223	$	97,095
Purchases of property, plant and equipment	24		25		27		32		240		347
Depreciation of property, plant and equipment	—		56		25		22		183		285